alexa Dissecting the In Vivo Leukemogenic Potency of Bclxl

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Global Summit On Oncology and Breast Cancer

Vienna, Austria

World Clinical Cancer Research and Diagnosis

Tokyo, Japan

Global Summit on Oncology and Cancer Therapy

New York, USA
Dissecting the In Vivo Leukemogenic Potency of Bclxl

Overexpression of anti-apoptotic members of the BCL2 family has been found in all types of cancer. A member of the family, BCLxl (B-cell lymphoma extra-large), is known to be associated with the progression of leukemogenesis. In the present study, we focused on understanding the domains of BCLxl responsible for in vivo oncogenic potency

Saurabh K, Scherzer MT, Song A, Yip KW, Reed JC, et al. (2014) Dissecting the In Vivo Leukemogenic Potency of Bclxl. J Leuk (Los Angel) 2:158

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Top